A detailed history of New Edge Advisors, LLC transactions in Alector, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 32 shares of ALEC stock, worth $157. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32
Previous 32 -0.0%
Holding current value
$157
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$5.86 - $7.93 $351 - $475
-60 Reduced 65.22%
32 $0
Q1 2023

May 12, 2023

SELL
$5.85 - $9.84 $573 - $964
-98 Reduced 51.58%
92 $0
Q4 2022

Feb 14, 2023

BUY
$6.88 - $9.55 $1,307 - $1,814
190 New
190 $1,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $406M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.